AI Ophthalmology and Optometry | Altris AI

Altris AI RUO Models for Dry AMD Research

Learn how Altris AI RUO Models support Dry AMD Research & Analysis

Book Intro AI Ophthalmology and Optometry | Altris AI

Altris IMS is an FDA-cleared (510(k)) image management system for OCT. Intended to support research workflows by enabling:

Identification and visualization of biomarkers related to Dry AMD.
Quantitative measurements of Dry AMD–related OCT imaging features, including confluent drusen, hard drusen, soft drusen, reticular pseudodrusen, RPE atrophy, hypertransmission, neurosensory retinal atrophy, vitelliform material, and chorioretinal scar.
Automated comparisons of imaging data across multiple visits can be viewed through percentage-based displays, maps, and graphs.

Research Use Only. Not for diagnostic procedures.

Platform overview

Only practical features for eye care specialists and clinical research

The security of patients’ data is our top priority: we are GDPR compliant, all data is encrypted, CE-certified, and FDA- cleared (510k).

Alisdair Buchanan Optometry Owner, UK

"Altris IMS has significantly enhanced the way we work with OCT scans."

Jeff Sciberras Optometry Owner

"The introduction of OCT with Altris IMS has transformed my practice literally overnight. The integration was seamless and Altris customer support has been outstanding."

Clara Pereira Optometrist, Portugal

"Altris IMS gives me an extra layer of certainty."

Dr. Sundeep Kheterpal Surgeon

"We are very happy with the outstanding customer service and support."

The system provides tools for research-focused review of longitudinal OCT data for US retina studies to observe changes associated with Dry AMD. Thus, the Pathology Progression module offers quantitative, image-derived measurements of selected Dry AMD-related features, including fine-scale changes, to support research analysis.

Efficient exploration of imaging features associated with Dry AMD for research workflows.
Quantitative characterization of biomarkers to support objective, repeatable research analysis.
Longitudinal visualization tools to study changes over time in OCT-derived measurements.
Research-focused review of drusen characteristics, including type, volume, area, and size, using the Drusen Count display.
Reproducible, automated measurements enable structured evaluation of OCT imaging features for research and analytical purposes. Research Use Only. Not for diagnostic procedures.

Add OCT examinations from different visits

Label Dry AMD biomarkers with color-coding

Explore the area and volume of biomarkers

Compare how Dry AMD changes in progression

How Altris IMS Works?

And how it supports the research and analysis of Dry AMD–related imaging features?

Altris IMS is a web-based platform developed with input from retina specialists to support eye-care professionals in reviewing and analyzing OCT imaging data.

Using a large repository of OCT scans with expert graphical annotations, the Altris AI Research Use Only (RUO) models are designed to:

Identify and characterize retinal imaging features and biomarkers, including those associated with Dry AMD, for research purposes only

Provide quantitative outputs to support consistent evaluation of OCT data across multiple studies

Enable longitudinal analysis of imaging features to study how they change over time in research workflows

Support research interpretation through objective, reproducible measurements and structured visualization tools

AI components are for Research Use Only. Not for diagnostic or therapeutic purposes.

Formats

DICOM format will help you to extract maximum information. The system works with all data formats.

OCT equipment

Altris IMS tool is vendor-neutral. We work with all the OCT equipment producers

OCT reports

We create comprehensible OCT reports for patients and doctors

For Pharma

For innovative approach in pharma

What you get:

Centralized OCT Data Management
Historical Data Analysis
Vendor-neutral analysis of OCT scans (8 manufacturers)
Data Security & Compliance
Additional capabilities for research
40+retinal biomarkers studied in research across 30+ retinal conditions. For Research Use Only. Not for diagnostic procedures.
Quantitative exploration of 40+biomarkers for Research Use Only. Not for diagnostic procedures.
Reports

For Eye Care

IMS for Ophthalmology and Optometry

What you get:

Centralized OCT Data Management
Vendor-Neutral OCT Compatibility (8 manufacturers)
Historical OCT Data Analysis
Seamless Clinical Workflow Integration
Informative OCT reports
40+retinal biomarkers studied in research across 30+ retinal conditions. For Research Use Only. Not for diagnostic procedures.
Quantitative exploration of 40+biomarkers for Research Use Only. Not for diagnostic procedures.

Contact us

Ask us any question

Book intro + free trial

Demo